Clinical Trial Update: A Comparison of Risperidone and Aripiprazole for Treatment of Patirnts With Methamphetamine-Associated Psychosis [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing risperidone and aripiprazole for methamphetamine-associated psychosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Dependence
• Methamphetamine-associated Psychosis

Drugs mentioned

• Abilify (aripiprazole)
• Risperdal (risperidone)

Snippet

Sponsor: Wei Hao | Conditions: Methamphetamine Dependence | Phase 4 | Status: TERMINATED